About: Efficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Efficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 23 June 2013

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 2013 (uk) im Juni 2013 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 23 June 2013 (en) artículu científicu espublizáu en xunu de 2013 (ast)
publication date	wds:Q86992619-EF9FD650-6220-48D6-B189-177D2A70DD70
publication date	2013-06-23 00:00:00Z (xsd:dateTime)
cites work	wds:Q86992619-079A71D9-5F49-43FD-966D-07B11902D844 wds:Q86992619-2619E491-4D9F-4CDF-9B45-E7C5293A675A wds:Q86992619-2D357765-A695-4E79-8024-DEC42670DD0B wds:Q86992619-2EE34FAE-1010-4648-B7C0-4BED64CFCA95 wds:Q86992619-3E8184A7-C0E7-4C92-963D-6E21EA65E30C wds:Q86992619-46A610FC-B9D2-4CB7-BC02-5B91731393E7 wds:Q86992619-54031C6D-F1CB-43EB-B5DA-F126AC9B93CC wds:Q86992619-6894134D-15B1-4878-9FE6-33ABABE53175 wds:Q86992619-71C666AA-6F8F-47F4-99C5-9353995A9AD1 wds:Q86992619-7340FC3D-F80C-43FB-AF02-762A77B3F38E wds:Q86992619-7CB744CF-C4C9-4D81-8186-2B2B79806CE6 wds:Q86992619-8B49E9CE-0B16-4A8F-B1C8-BC618085E128 wds:Q86992619-A67B0467-EAFE-475D-86E4-D5A153AD760B wds:Q86992619-AA7BFCB6-536B-4966-8E18-549132D64F0F wds:Q86992619-AEF28866-C6D2-4947-9822-BE23F97F5F40 wds:Q86992619-AF145225-0DC0-4A4E-98A8-8BBC6A8C6C23 wds:Q86992619-B02774D8-6515-41C9-A708-BDD3C2164F75 wds:Q86992619-DC5296C2-5B11-4857-A348-8FDF89F969BC wds:Q86992619-EF02A963-EEF9-4790-8D91-B81CED088665 wds:Q86992619-FD5329D4-0EAC-48E0-A4D7-13093326CC4B wds:Q86992619-FE25ABCA-7378-44A4-8701-5D16E3069226
cites work	Management of hepatocellular carcinoma Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: subset analyses of the phase III Sorafenib Asia-Pacific trial Molecular targeted therapies in hepatocellular carcinoma Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial Sorafenib in advanced hepatocellular carcinoma Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma. Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma Remission and survival following monthly intraarterial cisplatinum in nonresectable hepatoma Transcatheter arterial infusion chemotherapy with a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma refractory to transcatheter arterial chemoembolization Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma Is hepatic arterial infusion chemotherapy effective treatment for advanced hepatocellular carcinoma resistant to transarterial chemoembolization? Treatment strategies for hepatocellular carcinoma in Japan 5-fluorouracil arterial infusion + interferon therapy for highly advanced hepatocellular carcinoma: A multicenter, randomized, phase II study Hepatic arterial infusion chemotherapy using low-dose 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma
author name string	wds:Q86992619-17C2DCD1-E3B3-4592-A2D1-AE18094E3855 wds:Q86992619-19A340C5-6668-40B6-B69B-42316B413E84 wds:Q86992619-1BBAE16E-FB17-419D-B9FE-FA0C6F593E7A wds:Q86992619-254E2B35-54AD-4DFD-BDE5-F62A4654E7AD wds:Q86992619-46E6B4BE-8F88-4C27-A46B-F2B340E6484C wds:Q86992619-493A1192-7FB1-4A6B-8909-D66EF8FA88C1 wds:Q86992619-76EC2670-D1CE-4373-A079-6F0B3C30E144 wds:Q86992619-AD277919-D8F7-4C43-B579-FB6B3BCF96BD wds:Q86992619-C45A568C-E571-4E52-A501-CF940014581C wds:Q86992619-C4E0DEA7-F99D-476D-838C-9A00B64DBE93 wds:Q86992619-E0D47B63-C2BA-4377-AABB-6D82B0AE29CF wds:Q86992619-E2FA3D84-0172-48A7-9B38-BC324416ED78 wds:Q86992619-E9CB54DE-AC60-4D08-9924-6D30E64C9031
author name string	Hideaki Takahashi Masafumi Ikeda Takuji Okusaka Hideki Ueno Yasuaki Arai Satoshi Shimizu Shuichi Mitsunaga Chigusa Morizane Mitsuo Satake Shunsuke Kondo Akiko Kuwahara Izumi Ohno Hiroyuki Okuyama
rdfs:label	Efficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization (en) Efficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization (nl)
skos:prefLabel	Efficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization (en) Efficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization (nl)
name	Efficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization (en) Efficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization (nl)
title	wds:Q86992619-4C93AB52-827D-4B08-954A-A408FA0C6E08
title	Efficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization (en)
page(s)	wds:Q86992619-07D509CB-571A-4C7C-A003-8BE34B9F1B75
page(s)	932-940
instance of	wds:Q86992619-36350413-CA54-4EAB-AEE9-F03DCD59A3E5
instance of	scholarly article
main subject	wds:Q86992619-BD8A05F8-0F38-4517-AD2E-5552F6EE1283
main subject	hepatocellular carcinoma
PubMed ID	wds:Q86992619-35545133-CD1F-4E9C-B4DA-41C0F148083D
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23793266
PubMed ID	23793266
published in	wds:Q86992619-7C3D4DD4-8CE6-4665-B760-3F2F8E383B55
published in	Journal of Gastroenterology
issue	wds:Q86992619-2C2C0598-08D8-4086-9479-7D50B2647B36
volume	wds:Q86992619-9C98A3B5-2DAF-47E7-A385-4E0160638013
issue	5
volume	49
DOI	wds:Q86992619-EE9CA59A-2BB2-4372-9D1B-7B8056CCC889

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software